ARTICLE | Company News
CPMP recommends Arixtra, Vfend
December 14, 2001 8:00 AM UTC
Europe's Committee for Proprietary Medicinal Products (CPMP) recommended approval of Arixtra fondaparinux from Organon (Arnhem, the Netherlands) and partner Sanofi- Synthelabo (Paris, France) to prevent venous thromboembolic events following orthopedic surgery. Earlier this week the partners received FDA approval for the antithrombotic. ...